Novabion Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 19.22%
- Profit Growth 94.41%
- Ebitda 168.19%
- Net Worth -8.74%
- Total Assets -77.98%
About Novabion
Novabion Private Limited (NPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 07 November 2019 (Five years and three months 3 days old ). Its registered office is in Davangere, Karnataka, India.
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saranga Girimallikarjuna and Sahan Abblour serve as directors at the Company.
Company Details
-
Location
Davangere, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U50100KA2019PTC129440
-
Company No.
129440
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Nov 2019
-
Date of AGM
26 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Novabion Private Limited offer?
Novabion Private Limited offers a wide range of products and services, including Petroleum and Petrochemical Products, Biofuel, Turnkey Consultants & Solutions, Industrial project consultants.
Who are the key members and board of directors at Novabion?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saranga Girimallikarjuna
|
Director | 07-Nov-2019 | Current |
|
Sahan Abblour
|
Director | 07-Nov-2019 | Current |
Financial Performance of Novabion.
Novabion Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.22% increase. The company also saw a substantial improvement in profitability, with a 94.41% increase in profit. The company's net worth dipped by a decrease of 8.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novabion?
Unlock access to Novabion's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novabion?
Unlock and access historical data on people associated with Novabion, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novabion, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novabion's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.